yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A

RADIATION3 trials

Sponsors

City of Hope Medical Center

Conditions

Liver MetastasesRecurrent Colon CancerRecurrent Rectal CancerStage IV Colon CancerStage IV Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon Cancer

Phase 1

Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors

CompletedNCT00645060

City of Hope Medical CenterUnspecified Adult Solid Tumor, Protocol Specific

Start: 2006-10-09End: 2016-09-06Updated: 2020-02-27

Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

CompletedNCT01205022

City of Hope Medical CenterRecurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer +1

Start: 2011-04-30End: 2014-01-31Updated: 2015-06-08

Phase 2

Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

TerminatedNCT01320683

City of Hope Medical CenterLiver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer +4

Start: 2011-03-31End: 2014-12-31Updated: 2016-07-19